Business
Asia’s Most Innovative Country in 2019 is Singapore
Singapore (4th worldwide) has prioritised health and medicine in its national innovation strategy, including its AI development plan.

Continuing innovations in health and medicine have led to economic growth and a better quality of life for many around the world. But inequalities could grow rapidly.
Innovation and policies related to it are no longer solely the reserve of wealthy countries, as we have seen in more than a decade of the Global Innovation Index (GII). Innovators in developing economies show the world how to do more with less.
In India (52), for example, one company has found a way to use accessible technology for early diagnosis of a malady that often strikes premature babies and can blind them if not caught in time.
Rather than bringing expensive, complicated equipment to the Indian countryside, Remidio connects compact devices with a smartphone to diagnose retinopathy and enable speedy treatment for babies in far-flung regions.
Innovation transcends the tech sector, another example being the Eye Mitra programme, which uses a unique business model to finance healthcare at the base of the pyramid.

We have also seen impressive innovation examples with the use of drones to dispatch blood samples and medicines in Rwanda (94) and tele-care in large countries such as China (14).
Healthcare represents an increasingly important share of the global innovation ecosystem, which is why the theme of this year’s GII is “Creating Healthy Lives – The Future of Medical Innovation”.
A collaboration between INSEAD, Cornell University and the World Intellectual Property Organization (WIPO), the GII measures a country’s innovation performance based both on its innovation inputs (such as its regulatory environment, higher education, R&D spending and infrastructure) and its innovation outputs (such as its online creativity and knowledge creation).
Our global rankings are the premier tool worldwide for measuring innovation, which often establishes the competitive advantage of countries. In the GII, countries are benchmarked at the regional and income levels. The following image shows the leaders across these benchmarks:
Health and medical innovation is spreading

Ensuring healthy lives is Goal 3 in the UN’s Sustainable Development Goals (SDGs) for 2030. Innovation can boost health in myriad ways: Immunisation, universal health care and investment in the medical work force in developing countries can all be enhanced through innovation.
But innovation in other sectors can contribute too.
For instance, driverless cars could help reduce the number of deaths due to traffic accidents.
Looking to the future, the GII analyses the forthcoming medical innovation landscape, specifically how technological and non-technological medical innovation will transform the delivery of healthcare worldwide.
Singapore (4) has prioritised health and medicine in its national innovation strategy, including its AI development plan.
Opportunities could entail cancer immunotherapy, pain management relying on neuroscience without the use of opioids, or non-invasive spinal injury techniques to improve mobility for patients with paralysis.
Yet, innovation in health and medicine faces three kinds of challenges: ethical, social, economic
On the ethical side, genetic engineering requires a number of yet undefined principles and guidance both from the public and private points of view. The urgency is growing,…
Business
Thailand Approves Latest Economic Relief Package for Businesses
Some 250 billion baht (US$8 billion) was allocated for soft loans while the remaining 100 billion baht (US$3.2 billion) will go towards an ‘asset warehousing’ program whereby debtors can use their assets as loan collateral but will have the right to redeem their assets under a specific time frame.

On March 23, 2021, Thailand’s government approved its latest economic relief package, valued at 350 billion baht (US$11.2 billion), to support businesses in the country.
Business
Thailand BOI approves Biotech Projects Worth 2.4 Bln Baht ($78 million)
The biotechnology sector is part of the so-called BCG model (Bio, Circular and Green economy) which the Thai government has set as a priority to lead the post-Covid 19 recovery.

The Thailand Board of Investment (BOI) said today it has recently approved new projects in the field of advanced biotechnology, worth a combined 2.4 billion baht (around USD78 million) in investment, reflecting the increased interest of local and foreign investors in the country’s biotech sector.
Business
Asia-Pacific sees 3.9% growth in deal activity in February 2021

The Asia-Pacific (APAC) region saw a 3.9% month-on-month growth in deal activity (mergers & acquisitions, private equity and venture financing deals) from 1,126 deals to 1,170 deals in February 2021, according to GlobalData, a leading data and analytics company.
- Tourism1 week ago
Will Thailand’s plan for quarantine-free tourism set a global trend?
- Myanmar6 hours ago
Digital Revolution and Repression in Myanmar and Thailand
- Economics6 hours ago
Thai fruit exports to FTA markets up 107 percent
- Currencies2 days ago
3 Reasons to Be Optimistic About the Baht Right Now